Screening Tool Boosts Psoriatic Arthritis Detection

A single-center dermatology study found routine screening identified psoriatic arthritis in most patients with psoriasis who were evaluated.

Updated on Nov. 5, 2026 in Arthritis

Screening Tool Boosts Psoriatic Arthritis Detection

In an outpatient dermatology clinic, routine screening with the Psoriasis Epidemiology Screening Tool significantly increased detection of psoriatic arthritis among adults with dermatologist-confirmed psoriasis. Of 117 patients screened, 72 (61.5%) screened positive.

Why it matters

Psoriatic arthritis affects up to 30% of patients with psoriasis and can lead to irreversible joint damage in up to 20% of patients without timely treatment. Up to 40% of dermatology providers do not routinely screen for the condition, and limited visit time and uncertainty about next steps are cited as barriers.

The evidence is a single-center, nonrandomized controlled study in which 72 of 117 screened patients (61.5%) tested positive for psoriatic arthritis, a difference significant at P<0.001. Whether these findings generalize beyond this one outpatient dermatology clinic remains unknown.

The players

Psoriasis Epidemiology Screening Tool (PEST)

A structured questionnaire used to screen patients with psoriasis for psoriatic arthritis symptoms.

The details

Researchers screened adults with dermatologist-confirmed psoriasis using the Psoriasis Epidemiology Screening Tool. Patients who screened positive chose between biologic therapy alone and biologic therapy combined with a Mediterranean diet, and pain was reassessed after one month.

Pain severity was reassessed at 1 month after biologic therapy with or without the diet.

Health Landscape

Psoriatic arthritis is often missed in dermatology practice even though it affects nearly 3 million people in the United States, according to the study's estimate. The findings add evidence that structured screening within dermatology clinics, rather than referral alone, may close that detection gap.

Adults with psoriasis may ask their dermatologist whether they should be screened for joint symptoms, since pain severity was the one factor linked to a positive screen. Early identification gives patients the chance to begin treatment before irreversible joint damage develops.

The takeaway

Routine screening appears to catch psoriatic arthritis that would otherwise be missed, and patients with psoriasis reporting joint pain may benefit from raising it with their care team. Further multi-center research is needed to confirm these results.